Emergent BioSolutions Statistics
Total Valuation
EBS has a market cap or net worth of $468.96 million. The enterprise value is $877.76 million.
| Market Cap | 468.96M |
| Enterprise Value | 877.76M |
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EBS has 53.35 million shares outstanding. The number of shares has increased by 5.75% in one year.
| Current Share Class | 53.35M |
| Shares Outstanding | 53.35M |
| Shares Change (YoY) | +5.75% |
| Shares Change (QoQ) | -5.41% |
| Owned by Insiders (%) | 2.77% |
| Owned by Institutions (%) | 78.00% |
| Float | 51.88M |
Valuation Ratios
The trailing PE ratio is 3.48 and the forward PE ratio is 4.06.
| PE Ratio | 3.48 |
| Forward PE | 4.06 |
| PS Ratio | 0.56 |
| Forward PS | 1.04 |
| PB Ratio | 0.88 |
| P/TBV Ratio | 6.98 |
| P/FCF Ratio | 3.03 |
| P/OCF Ratio | 2.77 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.05, with an EV/FCF ratio of 5.66.
| EV / Earnings | 6.29 |
| EV / Sales | 1.03 |
| EV / EBITDA | 4.05 |
| EV / EBIT | 7.44 |
| EV / FCF | 5.66 |
Financial Position
The company has a current ratio of 5.66, with a Debt / Equity ratio of 1.26.
| Current Ratio | 5.66 |
| Quick Ratio | 2.73 |
| Debt / Equity | 1.26 |
| Debt / EBITDA | 3.12 |
| Debt / FCF | 4.36 |
| Interest Coverage | 2.25 |
Financial Efficiency
Return on equity (ROE) is 30.24% and return on invested capital (ROIC) is 5.96%.
| Return on Equity (ROE) | 30.24% |
| Return on Assets (ROA) | 5.03% |
| Return on Invested Capital (ROIC) | 5.96% |
| Return on Capital Employed (ROCE) | 9.15% |
| Revenue Per Employee | $946,222 |
| Profits Per Employee | $155,000 |
| Employee Count | 900 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 1.13 |
Taxes
In the past 12 months, EBS has paid $51.20 million in taxes.
| Income Tax | 51.20M |
| Effective Tax Rate | 26.85% |
Stock Price Statistics
The stock price has increased by +31.78% in the last 52 weeks. The beta is 1.98, so EBS's price volatility has been higher than the market average.
| Beta (5Y) | 1.98 |
| 52-Week Price Change | +31.78% |
| 50-Day Moving Average | 6.85 |
| 200-Day Moving Average | 7.52 |
| Relative Strength Index (RSI) | 66.22 |
| Average Volume (20 Days) | 1,448,300 |
Short Selling Information
The latest short interest is 9.95 million, so 18.65% of the outstanding shares have been sold short.
| Short Interest | 9.95M |
| Short Previous Month | 10.01M |
| Short % of Shares Out | 18.65% |
| Short % of Float | 19.18% |
| Short Ratio (days to cover) | 9.21 |
Income Statement
In the last 12 months, EBS had revenue of $851.60 million and earned $139.50 million in profits. Earnings per share was $2.53.
| Revenue | 851.60M |
| Gross Profit | 480.20M |
| Operating Income | 118.00M |
| Pretax Income | -578.10M |
| Net Income | 139.50M |
| EBITDA | 216.80M |
| EBIT | 118.00M |
| Earnings Per Share (EPS) | $2.53 |
Balance Sheet
The company has $267.30 million in cash and $676.10 million in debt, giving a net cash position of -$408.80 million or -$7.66 per share.
| Cash & Cash Equivalents | 267.30M |
| Total Debt | 676.10M |
| Net Cash | -408.80M |
| Net Cash Per Share | -$7.66 |
| Equity (Book Value) | 536.20M |
| Book Value Per Share | 9.99 |
| Working Capital | 592.40M |
Cash Flow
In the last 12 months, operating cash flow was $169.00 million and capital expenditures -$14.00 million, giving a free cash flow of $155.00 million.
| Operating Cash Flow | 169.00M |
| Capital Expenditures | -14.00M |
| Free Cash Flow | 155.00M |
| FCF Per Share | $2.91 |
Margins
Gross margin is 56.39%, with operating and profit margins of 13.86% and 16.38%.
| Gross Margin | 56.39% |
| Operating Margin | 13.86% |
| Pretax Margin | 22.39% |
| Profit Margin | 16.38% |
| EBITDA Margin | 25.46% |
| EBIT Margin | 13.86% |
| FCF Margin | 18.20% |
Dividends & Yields
EBS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.75% |
| Shareholder Yield | -5.75% |
| Earnings Yield | 29.75% |
| FCF Yield | 33.05% |
Analyst Forecast
The average price target for EBS is $14.33, which is 63.03% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.33 |
| Price Target Difference | 63.03% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 8.96% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EBS has an Altman Z-Score of 1.52 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.52 |
| Piotroski F-Score | 6 |